BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Intercell AG 

Campus Vienna Biocenter 6

Vienna    1030  Austria
Phone: 43-120620-0 Fax: 43-1-20620-800


SEARCH JOBS




Collaborations

Merck & Co., Inc.  Bacterial vaccines





 Company News
Vivalis to Buy Intercell AG in European Biotech Merger for $174 Million 12/17/2012 7:58:56 AM    More...
Intercell AG in Exploratory Talks With Private Equity, CEO Says 9/27/2011 8:12:47 AM    More...
Novartis AG Has No Need to Buy Intercell AG, According to Source 7/19/2011 8:14:16 AM    More...
Merck & Co., Inc. (MRK) and Intercell AG Announce Termination of Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710 6/8/2011 6:26:41 AM    More...
Intercell AG Announces Q1 2011 Results and Updates on R&D Progress 5/10/2011 9:41:18 AM    More...
Intercell AG Taps COO Lingelbach as New CEO 5/5/2011 8:07:11 AM    More...
Intercell AG, Merck & Co., Inc. (MRK) Told to Enroll No More Patients in Vaccine Clinical Test 4/11/2011 7:27:53 AM    More...
Intercell AG Announces Next Steps of Development for Pseudomonas Vaccine 4/1/2011 7:09:58 AM    More...
Intercell AG Announces Q4 and Preliminary Full Year 2010 Financial Results 3/1/2011 8:48:04 AM    More...
Intercell AG Completes Placement of EUR 33.0 Million Senior Convertible Debt Financing 2/23/2011 6:23:53 AM    More...
1234567

//-->